Literature DB >> 27188872

How similar are biosimilars?

Jeffrey K Aronson1, Robin E Ferner2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27188872     DOI： 10.1136/bmj.i2721

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  A novel approach to support implementation of biosimilars within a UK tertiary hospital.

Authors:  Katherine Saxby; Sonali Sanghvi; Pritesh N Bodalia; Robin E Ferner; Maria Leandro; Robert Urquhart; Reecha Sofat
Journal:  Br J Clin Pharmacol       Date:  2019-12-20       Impact factor: 4.335

2.  Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council.

Authors:  Arnon D Cohen; Ronald Vender; Luigi Naldi; Robert E Kalb; Tiago Torres; Murlidhar Rajagopalan; Joelle van der Walt; Lluís Puig; Helen S Young
Journal:  JAAD Int       Date:  2020-11-23

Review 3.  Me-too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists.

Authors:  Jeffrey K Aronson; A Richard Green
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

4.  Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan.

Authors:  Muna Oqal; Bushra Hijazi; Abdelrahim Alqudah; Ahmad Al-Smadi; Basima A Almomani; Roaa Alnajjar; Majd Abu Ghunaim; Mohammad Irshaid; Aroob Husam
Journal:  Int J Clin Pract       Date:  2022-06-27       Impact factor: 3.149
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.